Biodiversity and Intellectual Property Rights: An Analytical Perusal

This paper explores the intricate and often contentious relationship between biodiversity and Intellectual Property Rights (IPR), two legal frameworks that operate on fundamentally different principles. While biodiversity law, primarily governed by the Convention on Biological Diversity (CBD), emphasizes sovereign rights, collective heritage, and the equitable sharing of benefits, IPR systems focus on private ownership, individual innovation, and commercial exclusivity. The core of the conflict lies in the transition of biological resources—such as genes, microbes, and medicinal plants—from "common heritage" to "intellectual property." As biotechnology and pharmaceutical industries in the Global North increasingly utilize the genetic resources and traditional knowledge (TK) found in the biodiversity-rich Global South, issues of "bio piracy" have emerged. This occurs when traditional medicinal practices or indigenous genetic materials are patented without the prior informed consent of the source communities or a mechanism for fair remuneration. The paper further examines how the criteria for patentability—novelty, inventiveness, and industrial application—frequently fail to recognize the collective, oral, and intergenerational nature of traditional knowledge. This creates a legal loophole where ancient communal wisdom is rebranded as modern innovation. Additionally, the tension extends to agriculture, where plant variety protection can clash with farmers' traditional rights to save and exchange seeds.